AppAttic uses innovative tech solutions to help improve people’s health. Through apps and games, it collects and validates clinical data derived from mobile devices, and aims to evoke prolonged behavioural change in people with health conditions in order to reduce their costs and improve the quality of their life. One of its products, for instance, is a medicines-tracking game for mobile and tablet devices. The app engages users with their medicines schedule – recording their mood and heart rate and any non-adherence and reasoning. It gently nudges users to adhere to their prescribed medicines schedule through game experiences, rewards and competing with their peer-group.
How they’re disrupting
Engaging people in their own medicine routines and getting them to understand what leads them to skip their medicines is becoming a massive part of health education. AppAttic is providing health engagement and insight in a fun, tactile and innovative way. Its “games” approach means it is especially suitable for children who rely on medicines for their health, but need daily encouragement to take them.
The market in this area is expected to reach $5.98 billion by 2020, a rise of 12% from 2015. Among patients with chronic illness, approximately 50% do not take medications as prescribed. This poor adherence to medication leads to increased illness and death and is estimated to incur worldwide costs of approximately $100 billion per year, unless a solution is found.
Investments and future
AppAttic gained £50,000 from the In-Focus funding award for women in innovation. The company is focusing on creating technology to simplify clinical trials of mobile apps to validate their efficacy and user-adoption.